| scholarly article | Q13442814 |
| P2093 | author name string | Xinwei She | |
| Naoko Harada | |||
| Fumihiko Matsuno | |||
| Ben K Seon | |||
| Hilda Tsai | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 251-257 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells. | |
| P478 | volume | 108 |
| Q47137759 | A New Theranostic System Based on Endoglin Aptamer Conjugated Fluorescent Silica Nanoparticles |
| Q35201283 | Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature |
| Q35157425 | Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice |
| Q37058267 | Cancer prevention and therapy through the modulation of the tumor microenvironment |
| Q39508210 | Combination of recombinant xenogeneic endoglin DNA and protein vaccination enhances anti-tumor effects |
| Q41896516 | ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis |
| Q45875665 | Endoglin (CD105) Silencing Mediated by shRNA Under the Control of Endothelin-1 Promoter for Targeted Gene Therapy of Melanoma |
| Q36510958 | Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer |
| Q38180309 | Endoglin for targeted cancer treatment |
| Q37589238 | Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells |
| Q40251249 | Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction |
| Q37804900 | Endoglin-Targeted Cancer Therapy |
| Q35158941 | Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105) |
| Q35536671 | Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects. |
| Q92534987 | Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9 |
| Q54210210 | High expression of S100A4 and endoglin is associated with metastatic disease in head and neck squamous cell carcinoma. |
| Q24798737 | Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer |
| Q34098560 | Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin |
| Q35291271 | In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis |
| Q33957962 | Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors? |
| Q34672107 | Multiple delivery of siRNA against endoglin into murine mammary adenocarcinoma prevents angiogenesis and delays tumor growth |
| Q36285676 | Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers |
| Q35017120 | Positron emission tomography imaging of CD105 expression during tumor angiogenesis. |
| Q35026300 | Reducing endoglin activity limits calcineurin and TRPC-6 expression and improves survival in a mouse model of right ventricular pressure overload |
| Q55382872 | TGF-β1/CD105 signaling controls vascular network formation within growth factor sequestering hyaluronic acid hydrogels. |
| Q37610628 | Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours |
| Q37775427 | The physiological role of endoglin in the cardiovascular system. |
| Q88810807 | The prognostic correlation between CD105 expression level in tumor tissue and peripheral blood and sunitinib administration in advanced hepatocellular carcinoma |
| Q42483948 | Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial |
| Q37743207 | Tumor angiogenesis: insights and innovations |
| Q38962280 | Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma |
Search more.